Tech Company Financing Transactions

Aclaris Therapeutics Funding Round

On 10/25/2012, Aclaris Therapeutics raised $21 million in Series A funding from F-Prime Capital, Vivo Capital and Sofinnova Ventures.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

640 Lee Rd. 200
Wayne, PA 19087
USA

Phone

(484) 324-7933

Website

www.aclaristx.com

Email Address

[email protected]

Overview

Aclaris Therapeutics, Inc. (ACRS) is a specialty pharmaceutical company focused on identifying, developing and commercializing novel dermatologic treatments.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Neal Walker

        

Chief Financial Officer

Frank Ruffo

        

Chief Medical Officer

David Gordon

        

Chief Scientific Officer

Stuart Shanler

        

VP - General Counsel

Kamil Ali-Jackson

        

VP - R & D

Joseph Monahan

        

Browse more venture capital transactions:

Prev: 10/24/2012: BIOSAFE venture capital transaction
Next: 10/25/2012: Llamasoft venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary